These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 31375685)

  • 1. Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington's disease.
    Siew JJ; Chen HM; Chen HY; Chen HL; Chen CM; Soong BW; Wu YR; Chang CP; Chan YC; Lin CH; Liu FT; Chern Y
    Nat Commun; 2019 Aug; 10(1):3473. PubMed ID: 31375685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant huntingtin expression in microglia is neither required nor sufficient to cause the Huntington's disease-like phenotype in BACHD mice.
    Petkau TL; Hill A; Connolly C; Lu G; Wagner P; Kosior N; Blanco J; Leavitt BR
    Hum Mol Genet; 2019 May; 28(10):1661-1670. PubMed ID: 30624705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease.
    Hsiao HY; Chen YC; Chen HM; Tu PH; Chern Y
    Hum Mol Genet; 2013 May; 22(9):1826-42. PubMed ID: 23372043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 aggravates microglial activation and tau transmission in tauopathy.
    Siew JJ; Chen HM; Chiu FL; Lee CW; Chang YM; Chen HL; Nguyen TNA; Liao HT; Liu M; Hagar HT; Sun YC; Lai HL; Kuo MH; Blum D; Buée L; Jin LW; Chen SY; Ko TM; Huang JR; Kuo HC; Liu FT; Chern Y
    J Clin Invest; 2024 Jan; 134(2):. PubMed ID: 37988169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Galectin-3 Is Associated with Aging, Multiple Sclerosis, and Oxidized Phosphatidylcholine-Induced Neurodegeneration.
    Xue S; Lozinski BM; Ghorbani S; Ta K; D'Mello C; Yong VW; Dong Y
    J Neurosci; 2023 Jun; 43(25):4725-4737. PubMed ID: 37208177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease.
    Lu XH; Mattis VB; Wang N; Al-Ramahi I; van den Berg N; Fratantoni SA; Waldvogel H; Greiner E; Osmand A; Elzein K; Xiao J; Dijkstra S; de Pril R; Vinters HV; Faull R; Signer E; Kwak S; Marugan JJ; Botas J; Fischer DF; Svendsen CN; Munoz-Sanjuan I; Yang XW
    Sci Transl Med; 2014 Dec; 6(268):268ra178. PubMed ID: 25540325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma inflammatory biomarkers for Huntington's disease patients and mouse model.
    Chang KH; Wu YR; Chen YC; Chen CM
    Brain Behav Immun; 2015 Feb; 44():121-7. PubMed ID: 25266150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of glial cells to Huntington's disease pathogenesis.
    Wilton DK; Stevens B
    Neurobiol Dis; 2020 Sep; 143():104963. PubMed ID: 32593752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azadiradione Restores Protein Quality Control and Ameliorates the Disease Pathogenesis in a Mouse Model of Huntington's Disease.
    Singh BK; Vatsa N; Nelson VK; Kumar V; Kumar SS; Mandal SC; Pal M; Jana NR
    Mol Neurobiol; 2018 Aug; 55(8):6337-6346. PubMed ID: 29294248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Abl and Arg tyrosine kinases regulate lysosomal degradation of the oncoprotein Galectin-3.
    Li X; Ma Q; Wang J; Liu X; Yang Y; Zhao H; Wang Y; Jin Y; Zeng J; Li J; Song L; Li X; Li P; Qian X; Cao C
    Cell Death Differ; 2010 Aug; 17(8):1277-87. PubMed ID: 20150913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance.
    Li P; Liu S; Lu M; Bandyopadhyay G; Oh D; Imamura T; Johnson AMF; Sears D; Shen Z; Cui B; Kong L; Hou S; Liang X; Iovino S; Watkins SM; Ying W; Osborn O; Wollam J; Brenner M; Olefsky JM
    Cell; 2016 Nov; 167(4):973-984.e12. PubMed ID: 27814523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease.
    Martin B; Golden E; Carlson OD; Pistell P; Zhou J; Kim W; Frank BP; Thomas S; Chadwick WA; Greig NH; Bates GP; Sathasivam K; Bernier M; Maudsley S; Mattson MP; Egan JM
    Diabetes; 2009 Feb; 58(2):318-28. PubMed ID: 18984744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drp1/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington's disease.
    Joshi AU; Ebert AE; Haileselassie B; Mochly-Rosen D
    J Mol Cell Cardiol; 2019 Feb; 127():125-133. PubMed ID: 30550751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury.
    Lalancette-Hébert M; Swarup V; Beaulieu JM; Bohacek I; Abdelhamid E; Weng YC; Sato S; Kriz J
    J Neurosci; 2012 Jul; 32(30):10383-95. PubMed ID: 22836271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.
    Dufour BD; McBride JL
    Neurobiol Dis; 2019 Jan; 121():214-229. PubMed ID: 30292559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced immune response to MMP3 stimulation in microglia expressing mutant huntingtin.
    Connolly C; Magnusson-Lind A; Lu G; Wagner PK; Southwell AL; Hayden MR; Björkqvist M; Leavitt BR
    Neuroscience; 2016 Jun; 325():74-88. PubMed ID: 27033979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of galectin-3 and galectin-3-binding protein in venous thrombosis.
    DeRoo EP; Wrobleski SK; Shea EM; Al-Khalil RK; Hawley AE; Henke PK; Myers DD; Wakefield TW; Diaz JA
    Blood; 2015 Mar; 125(11):1813-21. PubMed ID: 25428218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
    Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
    Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Exogenous NUB1 Expression in the Striatum of HDQ175/Q7 Mice.
    Vodicka P; Chase K; Iuliano M; Valentine DT; Sapp E; Lu B; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M
    J Huntingtons Dis; 2016 Jun; 5(2):163-74. PubMed ID: 27314618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.